New research uncovers mechanisms behind heart damage from CTLA-4 blockade

Cytotoxic T-lymphocyte antigen 4 (CTLA-4) is a protein receptor on T immune cells that prevents the cells from killing other cells, such as cancer cells.

Cybin to Present at Public Ventures Discovery Day on March 19th in Dallas | Psychedelic Invest

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic-based

March 18, 2024

Plastic Glove, Scissors Solve Problem in Single-Lung Ventilation

SAN FRANCISCO — Chinese researchers reported a simple but clever solution to the problem of how to facilitate non-dependent lung collapse during single-lung ventilation, which

October 18, 2023

M&A activity in the pharmaceutical industry in Germany increased in 2023

In value terms, M&A activity in Germany remained flat in Q2 2023 compared with the previous quarter and as compared to Q2 2022. Related deal

August 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.